This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Cancer-associated thrombosis
  • /
  • Treatment of cancer-associated venous thromboembol...
Journal

Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomization of the SELECT-D Trial (SELECT-D: 12m)

Read time: 1 mins
Published:31st Mar 2020
Author: Marshall A, Levine M, Hill C, Hale D, Thirlwall J, Wilkie V et al.
Availability: Pay for access, or by subscription
Ref.:J Thromb Haemost. 2020 Apr;18(4):905-915.
DOI:10.1111/jth.14752.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest